Browsing by Author Hart, Derek

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 39  next >
Issue DateTitleAuthor(s)Citation
2013Alterations in Chemokine Receptor CCR5 Expression on Blood Dendritic Cells Correlate With Acute Graft-Versus-Host DiseaseBradstock, Kenneth; Hart, Derek; Sartor, Mary; Shahin, Kifah; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: ANZAC Research InstituteAlterations in Chemokine Receptor CCR5 Expression on Blood Dendritic Cells Correlate With Acute Graft-Versus-Host Disease, Transplantation, vol.96, 8, 2013,pp 753-762
2016The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell PopulationBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Gibson, John; Hart, Derek; Hsu, Jennifer; Hsu, Weihsun; Larsen, Stephen; Lee, Kenneth; Li, Ziduo; Lo, Tsunho; Silveira, Pablo; Alingcastre, Renz; Clarke, Candice; De, Barbarafazekas; Elgundi, Zehra; Ju, Xinsheng; Kupresanin, Fiona; McGuire, Helen; Verma, Nirupama; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteThe Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population, The Journal of Immunology, vol.197, 12, 2016,pp 4613-4625
2014Antibody therapy for acute myeloid leukaemiaBradstock, Kenneth; Clark, Georgina; Gasiorowski, Robin Edward; Hart, Derek; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteAntibody therapy for acute myeloid leukaemia, British Journal of Haematology, vol.164, 4, 2014,pp 481-495
2017Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell TransplantationBendall, Linda; Bradstock, Kenneth; Hart, Derek; Mattar, Zamil; Shahin, Kifah; Silveira, Pablo; Hsu, Wei-Hsun; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteBone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation, Transplantation, vol.101, 11, 2017,pp 2695-2704
2016A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Lee, Kenneth; Silveira, Pablo; Brown, Ross D.; Clarke, Candice; Cunningham, Ilona; Gibson, John; Kupresanin, Fiona; Newman, Elizabeth; Suen, Hayley; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteA CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset, Immunology and Cell Biology, vol.94, 5, 2016,pp 447-457
2016A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subsetBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho, Joy Phoebe; Joshua, Douglas; Lee, Kenneth; Silveira, Pablo; Brown, Ross D.; Clarke, Candice; Cunningham, Ilona; Gibson, John; Kupresanin, Fiona; Newman, Elizabeth; Suen, Hayley; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteA CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset, Immunology and Cell Biology, vol.94, 5, 2016,pp 447-457
2009The CD300 family of molecules are evolutionarily significant regulators of leukocyte functionsHart, Derek; Clark, Georgina; Ju, Xinsheng; Tate, Courtney; Concord Clinical School: ANZAC Research InstituteThe CD300 family of molecules are evolutionarily significant regulators of leukocyte functions, Trends in Immunology, vol.30, 5,pp 209-217
2013CD300 molecule regulation of human dendritic cell functionsClark, Georgina; Gasiorowski, Robin; Hart, Derek; Ju, Xinsheng; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteCD300 molecule regulation of human dendritic cell functions, Immunology Letters, vol.149, 1-2, 2013,pp 93-100
2009The CD300 molecules regulate monocyte and dendritic cell functionsHart, Derek; Azlan, Maryam; Clark, Georgina; Ding, Yitian; Ju, Xinsheng; Tate, Courtney; Concord Clinical School: ANZAC Research InstituteThe CD300 molecules regulate monocyte and dendritic cell functions, Immunobiology, vol.214, N/A,pp 730-736
2008CD300a/c regulate type I interferon and TNF-(alpha) secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligandsHart, Derek; Clark, Georgina; Ju, Xinsheng; Zenke, Martin; Concord Clinical School: ANZAC Research InstituteCD300a/c regulate type I interferon and TNF-(alpha) secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands, Blood, vol.112, N/A, 2008,pp 1184-1194
2012CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells T cells and are associated with poor prognosisGibson, John; Hart, Derek; Joshua, Douglas; Brown, Ross; Favaloro, James; Fromm, Phillip D; Joy Ho, P; Karieshma, Kabani; Nassif, Najah T; Suen, Hayley; Woodland, N. B.; Yang, Shihong; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: MedicineCD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells T cells and are associated with poor prognosis, Blood, vol.120, 10, 2012,pp 2055-2063
2011Cellular therapy to treat haematological and other malignancies: progress and pitfallsBradstock, Kenneth; Gottlieb, David; Hart, Derek; Frommer, P. D.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: ANZAC Research InstituteCellular therapy to treat haematological and other malignancies: progress and pitfalls, Pathology, vol.43, 6, 2011,pp 605-615
2016Characterization of the expression and function of the C-type lectin receptor CD302 in mice and humans reveals a role in dendritic cell migrationClark, Georgina; Cogger, Victoria Carroll; Fromm, Phillip; Hart, Derek; Lo, T; Silveira, Pablo; Verma, Nirupama; Adam, Rhonda; Kato, Masato; Kupresanin, Fiona; Vu, Phi A; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteCharacterization of the expression and function of the C-type lectin receptor CD302 in mice and humans reveals a role in dendritic cell migration, The Journal of Immunology, vol.197, 3, 2016,pp 885-898
2016CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responsesBradstock, Kenneth; Bryant, Christian; Clark, Georgina; Fromm, Phillip; Hart, Derek; Ho Lo, Tsun; Horvath, Lisa; Joshua, Douglas; Papadimitrious, Michael Stephen; Silveira, Pablo; Van Kooten Losio, Nicolas; Verma, Nirupama; Anguille, Sebastien; Barnard, Ross; et al, Various; Hsu, Jennifer; Mahler, Stephen; Munster, David; Nagasakid, Tomoko; Prue, R; Turtle, Cameron; Vukovic, Peter; Western Clinical School: Westmead Institute for Medical Res; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteCMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses, OncoImmunology, vol.5, 6, 2016,pp 1-12
2005Dendritic cell biology evolves into clinical applicationHart, Derek; Concord Clinical School: ANZAC Research InstituteDendritic cell biology evolves into clinical application, The Lancet, vol.365, 9454,pp 102-104
2015Dendritic Cells as Pharmacological Tools for Cancer ImmunotherapyBryant, Christian; Fromm, Phillip; Hart, Derek; Anguille, Sebastian; Berneman, Zwi N.; Goossens, Herman; Lion, Eva; Smits, Evelien; Van Acker, Heleen H; Van Tendeloo, Viggo; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: ANZAC Research InstituteDendritic Cells as Pharmacological Tools for Cancer Immunotherapy, Pharmacological Reviews, vol.67, 4, 2015,pp 731-753
2008Dendritic Cells in Cancer ImmunotherapyHart, Derek; Melief, Cornelis; Radford, Kristen; Vulink, Annelie; Concord Clinical School: ANZAC Research InstituteDendritic Cells in Cancer Immunotherapy, Advances in Cancer Research, vol.99, N/A,pp 363-407
2004Either Interleukin-12 Or Interferon-γ Can Correct The Dendritic Cell Defect Induced By Transforming Growth Factor β₁ In Patients With Myeloma.Gibson, John; Ho, Phoebe (Joy); Joshua, Douglas; Sze, Daniel; Brown, Ross; Hart, Derek; Murray, Allan; Pope, Belinda; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; PharmacyEither Interleukin-12 Or Interferon-γ Can Correct The Dendritic Cell Defect Induced By Transforming Growth Factor β₁ In Patients With Myeloma., British Journal of Haematology, vol.125,(2),2004,pp 743-748
2013A flow cytometry based assay for the enumeration of regulatory T cells in whole bloodHart, Derek; Hardy, Melinda; Prue, R; Rossetti, T; Vari, F; Concord Clinical School: ANZAC Research InstituteA flow cytometry based assay for the enumeration of regulatory T cells in whole blood, Journal of Immunological Methods, vol.390, 1-2, 2013,pp 121-126
2012Human CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coliHart, Derek; Ding, Yitian; Hardy, Melinda; Jongbloed, Sarah; Ju, Xinsheng; Kassianos, Andrew; McDonald, Kylie; Radford, Kristen J; Vijayan, Dipti; Vulink, Annelie; Wadley, Robert; Wells, Christine; Concord Clinical School: ANZAC Research InstituteHuman CD1c (BDCA-1)+ myeloid dendritic cells secrete IL-10 and display an immuno-regulatory phenotype and function in response to Escherichia coli, European Journal of Immunology, vol.42, 6, 2012,pp 1512-1522